RegulatoryAug 6, 2026, 08:09 AM
VivoSim Regains Nasdaq Compliance; Cash on Hand $10.1M
AI Summary
VivoSim Labs announced it has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires a minimum stockholders' equity of $2.5 million. This was achieved after receiving a $5.0 million milestone payment from Eli Lilly and a $1.0 million cash release from escrow, along with completing a financing round that generated approximately $3.6 million in net proceeds. As a result, the company's cash on hand reached approximately $10.1 million as of August 3, 2026. VivoSim also reiterated its guidance for over 500% revenue growth in Fiscal Year 2027.
Key Highlights
- Regained compliance with Nasdaq Listing Rule 5550(b)(1) for minimum stockholders' equity.
- Received $5.0 million milestone payment from Eli Lilly and Company.
- Received $1.0 million cash release from escrow.
- Completed financing, raising approximately $3.6 million in net proceeds.
- Cash on hand was approximately $10.1 million as of August 3, 2026.
- Issued 9,896,718 shares of common stock from warrant exercises in July.
- Anticipates 500%+ revenue growth in Fiscal Year 2027.
Price Impact
More from VIVS